These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7945792)

  • 1. Spectroscopic evidence for charge-transfer complexation in monoclonal antibodies that bind opiates.
    Droupadi PR; Meyers EA; Linthicum DS
    J Protein Chem; 1994 Apr; 13(3):297-306. PubMed ID: 7945792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption spectroscopy of the complexation between superpotent guanidinium sweeteners and specific monoclonal antibodies.
    Droupadi PR; Linthicum DS
    Int J Biochem Cell Biol; 1995 Apr; 27(4):351-7. PubMed ID: 7788557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the endogenous nonpeptide morphine-like compound to opiate receptors.
    Blume AJ; Shorr J; Finberg JP; Spector S
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4927-31. PubMed ID: 200939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal anti-idiotypic antibody to mu and delta opioid receptors.
    Coscia CJ; Szücs M; Barg J; Belcheva MM; Bem WT; Khoobehi K; Donnigan TA; Juszczak R; McHale RJ; Hanley MR
    Brain Res Mol Brain Res; 1991 Mar; 9(4):299-306. PubMed ID: 1645433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative sequence and immunochemical analyses of murine monoclonal anti-morphine antibodies.
    Miller A; Glasel JA
    J Mol Biol; 1989 Oct; 209(4):763-78. PubMed ID: 2555519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of allergenic cross-reactions--IV. Evidence for participation of aromatic residues in the ligand binding site of two multi-specific IgE monoclonal antibodies.
    Droupadi PR; Varga JM; Linthicum DS
    Mol Immunol; 1994 May; 31(7):537-48. PubMed ID: 8190129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of humoral endorphin on the binding of opiate agonists and antagonists.
    Sarne Y; Itzhak Y; Keren O
    Eur J Pharmacol; 1982 Jul; 81(2):227-35. PubMed ID: 6288405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecificity of 4,5-epoxymorphinan binding to the lambda site in rat brain.
    Yu VC; Jacobson AE; Rice KC; Sadée W
    Eur J Pharmacol; 1984 May; 101(1-2):161-2. PubMed ID: 6086361
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate receptor: cooperativity of binding observed in brain slices.
    Davis ME; Akera T; Brody TM; Watson L
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5764-6. PubMed ID: 202963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic antibodies that mimic opioids.
    Glasel JA; Agarwal D
    Methods Mol Biol; 1995; 51():183-201. PubMed ID: 7581697
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides.
    Chang KJ; Cooper BR; Hazum E; Cuatrecasas P
    Mol Pharmacol; 1979 Jul; 16(1):91-104. PubMed ID: 225656
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
    Csutoras C; Zhang A; Bidlack JM; Neumeyer JL
    Bioorg Med Chem; 2004 May; 12(10):2687-90. PubMed ID: 15110850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists.
    Feinberg AP; Creese I; Snyder SH
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4215-9. PubMed ID: 186791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of high-affinity monoclonal antibodies against morphine.
    Sawada J; Janejai N; Nagamatsu K; Terao T
    Mol Immunol; 1988 Sep; 25(9):937-43. PubMed ID: 3211162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and direct in vivo testing of mixture-based combinatorial libraries for the identification of highly active and specific opiate ligands.
    Houghten RA; Dooley CT; Appel JR
    AAPS J; 2006 May; 8(2):E371-82. PubMed ID: 16796388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate receptor binding affected differentially by opiates and opioid peptides.
    Childers SR; Creese I; Snowman AM; Synder SH
    Eur J Pharmacol; 1979 Apr; 55(1):11-8. PubMed ID: 220062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrofluorimetric study of the intermolecular complexation of monoclonal antibodies with the high potency sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl) guanidineacetic acid.
    Droupadi PR; Anchin JM; Meyers EA; Linthicum DS
    J Mol Recognit; 1992 Dec; 5(4):173-9. PubMed ID: 1339485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of secondary forces on the ligand binding properties and variable domain conformations of a monoclonal anti-fluorescyl antibody.
    Mummert ME; Voss EW
    Mol Immunol; 1996 Sep; 33(13):1067-77. PubMed ID: 9010246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.